1 Assistant Commissioner, Department of Health, New York City
There is at present much interest over the new regulations of the U.S. Food and Drugs Administration, requiring that the generic names shall accompany the trade name of drugs in advertisements and trade literature. This raises the question as to whether the same parallel requirement might not be imposed by editors in papers concerned with drugs. Often only the generic name appears in the title, especially if the article deals with some unfavorable aspect of the drug.